About PGxl

PGXL is an internationally recognized pioneer in the application of molecular diagnostics to pharmacogenetics and is the first laboratory to be CLIA-certified specifically for pharmacogenetics testing. The company was founded in 2005 by Dr. Roland Valdes, Jr., and Dr. Mark W. Linder, researchers who are among the worldwide thought leaders in the science underlying personalized medicine. Our scientists are leading the way in the incorporation of genetic information into the practice of medicine.

News

PGxl Blog

  • More DEPArray/PGXL Technologies

    Business First picked up the news that PGXL Technologies is adding the DEPArray. It's a nice little backgrounder aimed at ...

  • Genome Plus 10

    HealthDay marks the tenth anniversary of the mapping of the human genome with a State of Genomic Medicine piece that ...

  • Pharmacogenetics Marches On

    Construction has started on another expansion of PGXL. We're tripling lab space, including the addition of a full molecular lab. ...

  • Gaming Drug Development and Therapy

    The Director of Digital for pharmaceutical group Boehringer Ingelheim GmbH, John Pugh, thinks there's a future for gaming in drug ...